STARNSEStrides Pharma Science Limited· PharmaceuticalsMinimalNeutral
Announced Thu, 26 Jun · 20:22 IST

Pronoz Ventures LLP has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

STAR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Pronomz Ventures LLP, part of the promoter group of Strides Pharma Science Limited, has filed a compliance declaration with the stock exchanges. The filing confirms that the promoters and promoter group have not created any new encumbrance (such as pledge or charge) on the company's shares during the financial year ended March 31, 2025, beyond what was already disclosed earlier. This is a routine annual compliance submission required under SEBI takeover regulations.

Likely market impact

This is a neutral compliance filing with no material impact on the stock. It simply reassures investors that promoters have not added new pledges or charges on their holdings, indicating no hidden financial stress at the promoter level for FY25.